Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1903 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
Rank Status Study
21 Recruiting Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America
Condition: Zika Virus Infection on Fetus and Child During the Pregnancy
Interventions: Other: fundus examination;   Other: Head ultrasound
22 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
23 Not yet recruiting A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
24 Unknown  e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses
Conditions: Cervical Cancer;   Human Papilloma Virus Infection
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
25 Not yet recruiting Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant
Conditions: Disorder Related to Renal Transplantation;   Immunosuppression Related Infectious Disease;   Virus Diseases
Interventions: Drug: mTOR inhibitor (everolimus);   Drug: cyclosporine or tacrolimus
26 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
27 Recruiting Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV LID cp ΔM2-2 Vaccine;   Biological: Placebo
28 Recruiting A Study of the Safety and Efficacy of EBV Specific T-cell Lines
Conditions: Epstein-Barr Virus Infections;   Post-Transplant Lymphoproliferative Disorder;   Lymphoma
Interventions: Biological: Group A;   Biological: Group B
29 Recruiting Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
Condition: Hepatitis C Virus
Intervention: Drug: SOF
30 Recruiting Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Intervention: Drug: SOF/VEL
31 Recruiting A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection
Conditions: Hepatitis C Viral Infection;   Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: Faldaprevir;   Drug: TD-6450;   Drug: Ribavirin
32 Unknown  Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
Condition: Chronic Hepatitis C Virus Infection
33 Recruiting Clinical Trial of Efficacy of Anaferon for Children® in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
Condition: Influenza and Acute Respiratory Viral Infections
Interventions: Drug: Anaferon for children;   Drug: Placebo
34 Unknown  Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatitis B Virus;   Recurrence
Interventions: Drug: antiviral treatment (lamivudine or entecavir);   Procedure: radical resection of HBV-related HCC
35 Recruiting Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Conditions: Hepatitis;   Hepatitis C;   Digestive System Diseases;   Flaviviridae Infections;   Hepatitis, Viral, Human;   Liver Diseases;   RNA Virus Infections;   Virus Diseases
Interventions: Drug: MK- 3682B;   Drug: Ribavirin
36 Not yet recruiting A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: MEDI8897;   Drug: Placebo
37 Recruiting A Study of ALS-008176 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
38 Unknown  Virus Surveillance in Pediatric Solid Organ Transplant Recipients
Condition: Viral Infections
39 Recruiting Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
Condition: Ebola Virus Survivor
Intervention: Drug: Favipiravir
40 Unknown  The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Conditions: Cytomegalovirus;   Epstein-Barr Virus Infections;   Herpesvirus Infection

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years